Concerns about liver toxicity are fueling changes for pemoline and Cymbalta

Concerns about liver toxicity are fueling changes for pemoline and Cymbalta.

Pemoline will go off the market...due to liver failure.

Your patients can continue to receive pemoline until it runs out. But switch to a different ADHD med as soon as possible.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote